OA11350A - Dofetilide polymorphs. - Google Patents

Dofetilide polymorphs. Download PDF

Info

Publication number
OA11350A
OA11350A OA1200000117A OA1200000117A OA11350A OA 11350 A OA11350 A OA 11350A OA 1200000117 A OA1200000117 A OA 1200000117A OA 1200000117 A OA1200000117 A OA 1200000117A OA 11350 A OA11350 A OA 11350A
Authority
OA
OAPI
Prior art keywords
dofetilide
polymorph
dofetilide polymorph
dofetiiide
shows
Prior art date
Application number
OA1200000117A
Other languages
English (en)
Inventor
Ian Colin Appleby
Gary Nichols
Trevor Jack Newbury
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10821150&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA11350(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of OA11350A publication Critical patent/OA11350A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
OA1200000117A 1997-10-27 2000-04-20 Dofetilide polymorphs. OA11350A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722662.5A GB9722662D0 (en) 1997-10-27 1997-10-27 Polymorphs

Publications (1)

Publication Number Publication Date
OA11350A true OA11350A (en) 2003-12-17

Family

ID=10821150

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200000117A OA11350A (en) 1997-10-27 2000-04-20 Dofetilide polymorphs.

Country Status (47)

Country Link
US (1) US6124363A (uk)
EP (1) EP1027329B1 (uk)
JP (1) JP3569495B2 (uk)
KR (1) KR100366167B1 (uk)
CN (1) CN1146537C (uk)
AP (1) AP906A (uk)
AR (1) AR015193A1 (uk)
AT (1) ATE232199T1 (uk)
AU (1) AU737668B2 (uk)
BG (1) BG64125B1 (uk)
BR (1) BR9813308A (uk)
CA (1) CA2307121C (uk)
CO (1) CO4970768A1 (uk)
DE (1) DE69811256T2 (uk)
DK (1) DK1027329T3 (uk)
DZ (1) DZ2632A1 (uk)
EA (1) EA002656B1 (uk)
ES (1) ES2190620T3 (uk)
GB (1) GB9722662D0 (uk)
GT (1) GT199800165A (uk)
HK (1) HK1033933A1 (uk)
HN (1) HN1998000165A (uk)
HR (1) HRP20000247B1 (uk)
HU (1) HUP0004735A3 (uk)
ID (1) ID24658A (uk)
IL (1) IL135435A0 (uk)
IS (1) IS2179B (uk)
MA (1) MA24683A1 (uk)
MY (1) MY123352A (uk)
NO (1) NO325630B1 (uk)
NZ (1) NZ503785A (uk)
OA (1) OA11350A (uk)
PA (1) PA8462001A1 (uk)
PE (1) PE122199A1 (uk)
PL (1) PL197379B1 (uk)
PT (1) PT1027329E (uk)
SA (1) SA98190834B1 (uk)
SI (1) SI1027329T1 (uk)
SK (1) SK5862000A3 (uk)
TN (1) TNSN98193A1 (uk)
TR (1) TR200001135T2 (uk)
TW (1) TW449589B (uk)
UA (1) UA67755C2 (uk)
UY (2) UY25222A1 (uk)
WO (1) WO1999021829A1 (uk)
YU (1) YU24000A (uk)
ZA (1) ZA989719B (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019067C1 (de) * 2000-04-18 2001-10-04 Lohmann Therapie Syst Lts Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung
US7326772B2 (en) * 2005-05-12 2008-02-05 Penta Biotech, Inc. Peptide for assaying hERG channel binding
CZ307826B6 (cs) 2017-12-01 2019-05-29 Farmak, A.S. Způsob přípravy N-[4-(2-{[2-(4-methansulfonamidofenoxy)ethyl](methyl)amino}ethyl)fenyl]methansulfonamidu (Dofetilidu)
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
EP0898964A1 (en) * 1997-08-19 1999-03-03 Pfizer Inc. Method for treating heart failure

Also Published As

Publication number Publication date
BR9813308A (pt) 2000-08-22
HK1033933A1 (en) 2001-10-05
PE122199A1 (es) 1999-12-02
TW449589B (en) 2001-08-11
IS5426A (is) 2000-03-31
PL197379B1 (pl) 2008-03-31
UY25222A1 (es) 2000-12-29
US6124363A (en) 2000-09-26
SK5862000A3 (en) 2001-10-08
KR20010031439A (ko) 2001-04-16
DE69811256D1 (de) 2003-03-13
IL135435A0 (en) 2001-05-20
KR100366167B1 (ko) 2003-01-09
DZ2632A1 (fr) 2003-03-08
ATE232199T1 (de) 2003-02-15
NO20002191D0 (no) 2000-04-27
ES2190620T3 (es) 2003-08-01
EP1027329B1 (en) 2003-02-05
AP906A (en) 2000-11-30
BG104373A (en) 2000-12-29
AU2151299A (en) 1999-05-17
JP2001521023A (ja) 2001-11-06
PT1027329E (pt) 2003-04-30
SI1027329T1 (en) 2003-04-30
PA8462001A1 (es) 2000-05-24
UA67755C2 (uk) 2004-07-15
DK1027329T3 (da) 2003-02-24
AP9801371A0 (en) 1998-12-31
MY123352A (en) 2006-05-31
IS2179B (is) 2006-12-15
GT199800165A (es) 2000-04-19
YU24000A (sh) 2003-02-28
AR015193A1 (es) 2001-04-18
CN1278246A (zh) 2000-12-27
UY25341A1 (es) 1999-09-27
BG64125B1 (bg) 2004-01-30
TR200001135T2 (tr) 2000-09-21
TNSN98193A1 (fr) 2005-03-15
EP1027329A1 (en) 2000-08-16
CN1146537C (zh) 2004-04-21
HUP0004735A2 (hu) 2001-10-28
EA002656B1 (ru) 2002-08-29
AU737668B2 (en) 2001-08-30
EA200000365A1 (ru) 2000-12-25
DE69811256T2 (de) 2003-09-18
CO4970768A1 (es) 2000-11-07
WO1999021829A1 (en) 1999-05-06
GB9722662D0 (en) 1997-12-24
PL340805A1 (en) 2001-02-26
HRP20000247B1 (en) 2002-08-31
CA2307121A1 (en) 1999-05-06
NO325630B1 (no) 2008-06-30
HUP0004735A3 (en) 2001-12-28
CA2307121C (en) 2006-12-05
HRP20000247A2 (en) 2000-10-31
NZ503785A (en) 2004-11-26
ID24658A (id) 2000-07-27
NO20002191L (no) 2000-04-27
HN1998000165A (es) 1999-02-09
ZA989719B (en) 2000-04-26
JP3569495B2 (ja) 2004-09-22
SA98190834B1 (ar) 2006-08-21
MA24683A1 (fr) 1999-07-01

Similar Documents

Publication Publication Date Title
DE69425736T2 (de) Formyl- oder Cyano- substituierte Indolderivate mit dopaminergischer Wirkung
DE69428903T2 (de) Substituierte 2-aminotetraline
JP3462165B2 (ja) 神経筋遮断剤
DE3875600T2 (de) Antiarrythmische derivate 2.
JPS6344572A (ja) 抗不整脈剤
EP0161599A2 (de) Neue Benzazepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
OA11350A (en) Dofetilide polymorphs.
JPS6126996B2 (uk)
EP0074014A1 (de) 2-(2'-Hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, seine Säureadditionssalze, Verfahren zu seiner Herstellung und Arzneimittel
JPH02167279A (ja) アポビンカミン酸誘導体
PT87219B (pt) Processo para a preparacao de sulfonildeca-hidro-8h-isoquino{2,1-g} {1,6}naftiridinas, de seus isomeros opticos e de compostos afins
DE69022442T2 (de) Aminoalkoxyphenyl-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Zusammensetzungen.
JPH0633247B2 (ja) ３―アミノプロポキシフェニル誘導体およびその製法ならび用途
KR880001009B1 (ko) 디하이드로리세르그산 에스테르 및 그의 제조방법
MXPA00004059A (en) Dofetilide polymorphs
CZ20001516A3 (cs) Polymorfy dofetilidu
CN112851599B (zh) 一种具有双阳离子季铵盐结构的化合物及其制备方法和用途
EP3939578A1 (en) Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease
US6774263B1 (en) Pharmaceutically active compound and methods of use
IL47060A (en) Quaternary ammonium salts of n-dialkylaminoalkyl-n-(2-indanyl)anilines
CN116120327A (zh) β-榄香烯13,14-位对称的双取代衍生物及其制备方法和应用
JPS6112624A (ja) 抗高血圧剤
CA2306276A1 (en) Pharmaceutically active compound and methods of use
WO1999009001A1 (fr) Derives de phenylethanolaminotetraline et bronchodilatateurs
JPH01153663A (ja) 血圧降下剤